Humana Delaware Weight Loss Treatment Coverage | Klarity Health

Humana Delaware: Weight Loss Treatment Coverage Guide

Humana plans in Delaware may cover weight loss treatment under your medical benefits. In Delaware, Humana operates exclusively as a Medicare Advantage (MAPD) carrier. As of July 1, 2026, eligible Humana MAPD members may access GLP-1 weight loss medications through the Medicare GLP-1 Bridge at $50/month via a CMS-administered program. You can check whether your Humana plan may cover care at Klarity before booking.

Medicare GLP-1 Bridge: Major 2026 Update for Humana MAPD Members

Effective July 1, 2026, the CMS-administered Medicare GLP-1 Bridge program allows eligible Humana Medicare Advantage members to access FDA-approved GLP-1 weight loss medications, including Wegovy (semaglutide), Zepbound (tirzepatide), and Foundayo (semaglutide), at a fixed $50 per month cost-share. This coverage is provided outside the standard HPS Part D formulary. Prior authorization based on CMS eligibility criteria (including BMI thresholds and qualifying comorbidities) is required. Contact Humana at 1-800-448-6262 to confirm your plan's participation and initiate the authorization process.

How Humana May Cover Weight Loss Treatment in Delaware

Humana Medicare Advantage plans in Delaware are governed by federal CMS regulations (42 CFR Part 422). Delaware's mental health parity law (Del. Code Ann. tit. 18, § 3343) does not govern weight loss benefits, and weight loss treatment is not subject to parity requirements under state or federal MHPAEA.

Key facts for Humana MAPD members in Delaware seeking weight loss coverage:

• Medicare GLP-1 Bridge: Wegovy, Zepbound, and Foundayo may be available at $50/month for eligible MAPD members via the CMS program (outside standard HPS Part D formulary). This is the primary pathway for GLP-1 weight loss coverage.
• Standard HPS Part D formulary: Most dedicated weight loss medications have historically been excluded under the Medicare Part D weight loss drug exclusion. The GLP-1 Bridge creates an alternative access pathway.
• EPCS: GLP-1 medications (semaglutide, tirzepatide) are non-scheduled; Delaware EPCS requirements do not apply. Phentermine and Qsymia are Schedule IV controlled substances and require EPCS under Delaware law. Both are excluded from Medicare Part D coverage.
• Appeals: Coverage denials should be directed to the federal Medicare appeals process (Humana redetermination → Maximus IRE 1-855-887-6668 → ALJ). The Delaware Bureau of Insurance has limited jurisdiction over MAPD decisions.

Dual-eligible members (Medicare + Delaware Medicaid/DelawareCare) may have additional weight loss coverage pathways. Contact Delaware DHSS at 1-800-372-2022 or Delaware SHIP at 1-800-336-9500 for guidance.

Frequently Asked Questions

Q: Does Humana cover weight loss treatment in Delaware?
Humana Medicare Advantage members in Delaware may access GLP-1 weight loss medications through the Medicare GLP-1 Bridge at $50/month (effective July 1, 2026). Coverage is subject to CMS eligibility criteria and prior authorization. Verify your benefits before booking.

Q: Does Humana cover GLP-1 weight loss medication in Delaware?
Eligible Humana MAPD members in Delaware may access Wegovy, Zepbound, and Foundayo at $50/month through the Medicare GLP-1 Bridge program (CMS-administered, outside standard HPS formulary). Prior authorization is required. Contact Humana at 1-800-448-6262 or HPS at 1-800-379-0092 to verify eligibility.

Q: Is Klarity Health in-network with Humana in Delaware?
Klarity Health works with many insurance plans. Network status varies by plan type. Use Klarity's benefits check to verify whether your Humana plan may cover weight loss care at Klarity.

Q: What is the copay for weight loss treatment with Humana in Delaware?
Eligible MAPD members may access GLP-1 medications at $50/month through the CMS GLP-1 Bridge. Consultation copays vary by plan. Review your Humana plan documents or call member services for your specific cost-share.

Q: Does Humana require prior authorization for weight loss medication in Delaware?
Yes. Prior authorization through the CMS GLP-1 Bridge pathway is required. Your provider must document BMI, qualifying comorbidities, and weight management history. Contact Humana or HPS to obtain prior authorization forms.

Q: Does Humana cover online weight loss treatment in Delaware?
Some Humana Medicare Advantage plans may cover telehealth weight loss consultations. Telehealth coverage is subject to your plan's specific benefits under CMS telehealth rules. Verify with Humana before booking.

Q: How do I verify my Humana coverage for weight loss in Delaware?
Call Humana member services at 1-800-448-6262, contact HPS at 1-800-379-0092, or use Klarity's benefits verification tool at helloklarity.com to check whether your plan may cover weight loss care.

Q: What Humana plans may cover weight loss medication in Delaware?
Humana Medicare Advantage plans may provide access to GLP-1 weight loss medications through the Medicare GLP-1 Bridge at $50/month. Commercial plans are not available from Humana in Delaware. Confirm your plan's participation in the Bridge program with Humana or HPS.

Insurance coverage varies by plan, insurer, and state. The information on this page is intended as general guidance only and does not constitute a guarantee of benefits. Telehealth provider availability may vary by state. Please verify your specific plan's mental health coverage with your insurer or through Klarity's benefits check before booking. Humana Medicare Advantage plans are governed by federal CMS regulations (42 CFR Part 422). The Medicare GLP-1 Bridge program details are subject to change by CMS. Coverage disputes should be directed to the federal Medicare appeals process, not the Delaware Bureau of Insurance.

Check if your Humana plan may cover weight loss treatment in Delaware